CP-LC-1422
CP-LC-1422 is a homocysteine-derived ionizable amino lipid with high RNA delivery capability and can mediate high-level protein expression in vivo. CP-LC-1422 exhibits significant spleen targeting via intravenous injection in a lipid nanoparticle (LNP) formulation with no significant toxicity observed[1].
Product Specifications
UNSPSC
12352211
Target
Liposome
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Others
Smiles
O=C(C(NC(CCCCC(SCCC(OCCCCCC(C)C)=O)CCSCCC(OCCCCCC(C)C)=O)=O)CCSCCC(OCCCCCCCC(C)C)=O)NCCN(C)C
Molecular Formula
C51H97N3O8S3
Molecular Weight
976.53
References & Citations
[1]Jörgensen AM, et al. Biodegradable Cationic and Ionizable Cationic Lipids: A Roadmap for Safer Pharmaceutical Excipients. Small. 2023 Apr;19 (17) :e2206968.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB1793-100 1x 100 µL
HSV1 (Herpes Simplex Virus Type I) (10A3), 0.2mg/mL
Sign In for Pricing
View Details 
TP720421 10 µg
TrkB (NTRK2) (NM_001007097) Human Recombinant Protein
Sign In for Pricing
View Details 
